246 studies found for:    Open Studies | "Hepatitis B"
Show Display Options
Rank Status Study
21 Unknown  Seroprevalence of Hepatitis B Infection and Effect of Booster Response Amongst Taiwanese Young Adults
Condition: Hepatitis B
Intervention:
22 Unknown  A Single-Arm Study Evaluating the Efficacy of Liquid Acupuncture Therapeutics in Chronic Hepatitis B
Conditions: Hepatitis B, Chronic;   Liver Diseases;   Virus Diseases;   Hepatitis;   Diffuse Hepatic Disease
Intervention: Device: Liquid Acupuncture (Herb Acupoint Injection)
23 Unknown  Prednisolone Priming Study in Patients With Chronic Hepatitis B
Condition: Chronic Hepatitis B
Interventions: Drug: Prednisolone;   Drug: Placebo priming
24 Recruiting Hepatitis B Research Network Pediatric Cohort Study (HBRN)
Condition: Hepatitis B
Intervention:
25 Unknown  Safety and Efficacy of Telbivudine on Liver Cirrhosis in Patients With Chronic Hepatitis B (CHB)
Conditions: Liver Cirrhosis;   Chronic Hepatitis B
Intervention: Drug: telbivudine
26 Unknown  Adolescents' Response to Hepatitis B Vaccine Booster Dose
Condition: Hepatitis B
Intervention: Biological: hepatitis B vaccine
27 Recruiting Abatacept vs Placebo in RA Patients With Hepatitis B on Entecavir Background
Conditions: Rheumatoid Arthritis;   Chronic Hepatitis B
Interventions: Drug: Abatacept;   Drug: Placebo
28 Recruiting Safety and Efficacy Study of NVR 3-778 in Healthy Volunteers and Hepatitis B Patients
Condition: Chronic Hepatitis B
Interventions: Drug: NVR 3-778;   Drug: Placebo for NVR 3-778;   Drug: Pegasys
29 Recruiting Prospective Observational Cohort Study for the Durability of Anti-viral Therapy in Patients With Chronic Hepatitis B
Condition: Chronic Hepatitis B
Intervention:
30 Recruiting Efficacy of Switching or Adding Pegylated Interferon in Chronic Hepatitis B Patients on Long Term Oral Antiviral Therapy
Condition: Chronic Hepatitis B
Interventions: Drug: peg-interferon alpha 2b, 1.5mcg/kg s/c given weekly;   Drug: Nucleos(t)ide analogue therapy
31 Unknown  Pegylated Interferon Alfa-2b Plus Ribavirin in Chronic Hepatitis B and Delta
Conditions: Chronic Hepatitis B;   Chronic Hepatitis D
Intervention: Drug: pegylated IFN alfa-2b plus ribavirin
32 Unknown  Pegasys Plus Entecavir Versus Entecavir Alone for Hepatitis Be Antigen-Positive Chronic Hepatitis B
Condition: Chronic Hepatitis B
Interventions: Drug: Pegasys plus Entecavir;   Drug: Entecavir
33 Recruiting Pegasys Plus Entecavir Versus Entecavir Versus Pegasys for Hepatitis B e Antigen-Negative Chronic Hepatitis B
Condition: Chronic Hepatitis B
Intervention: Drug: Pegasys&Entecavir
34 Recruiting PEG-interferon Alfa-2a add-on Study in HBeAg Negative Chronic Hepatitis B Patients
Condition: Chronic Hepatitis B
Interventions: Drug: Peginterferon alfa-2a;   Drug: Nucleos(t)ide analogue
35 Recruiting Safety and Efficacy of GS-9620 for the Treatment of Chronic Hepatitis B Virus in Virally-Suppressed Subjects
Condition: Chronic Hepatitis B
Interventions: Drug: GS-9620;   Drug: Placebo to match GS-9620
36 Recruiting Sustained Off-treatment Response After HBeAg Loss in Chronic Hepatitis B Patients Treated With Nucleos(t)Ide Analogues
Condition: Chronic Hepatitis B
Interventions: Drug: Continue NA treatment;   Drug: Discontinue NA Treatment
37 Not yet recruiting Efficacy and Safety Study of Tenofovir Disoproxil Fumarate (TDF) in Chinese Chronic Hepatitis B (CHB) Subjects With Advanced Fibrosis & Compensated Cirrhosis
Condition: Hepatitis B, Chronic
Intervention: Drug: Tenofovir disoproxil fumarate
38 Unknown  Efficacy and Safety of Dual-plasmid Hepatitis B Virus DNA Vaccine in Chronic Hepatitis B Patients
Condition: Chronic Hepatitis B
Interventions: Biological: HBV DNA vaccine;   Other: Placebo
39 Unknown  Pegylated Interferon Alpha-2b Monotherapy Versus Combination With Entecavir in HBeAg-negative Chronic Hepatitis B
Condition: Chronic Hepatitis B
Intervention: Drug: PEG-IFN and entecavir
40 Unknown  Switch From Adefovir to Tenofovir in Chronic Hepatitis B for Suboptimal Response to Adefovir-based Combination Therapy
Condition: Chronic Hepatitis B
Intervention: Drug: Switching from adefovir (10mg/day) to tenofovir (300mg/day)

First Page    Show previous page of results Previous Page (1-20) Studies Shown (21-40) Next Page (41-60) Show next page of results    Last Page
Indicates status has not been verified in more than two years